![NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24 Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria](https://cdn.cancerletter.com/media/2023/10/13155956/49-38-4x3-1.jpg)
![NCI’s RPG pool, cancer centers, training awards, SPOREs, and intramural research likely to face cuts in FY24 Center directors are concerned about NCI’s proposal to create a tier of centers with lower eligibility criteria](https://cdn.cancerletter.com/media/2023/10/13155956/49-38-4x3-1.jpg)
Cover Story
NCI Director's Report
By Alexandria Carolan and Paul Goldberg
Amid the gridlock that has seized Washington, NCI faces a grim and disturbing FY2024, the institute’s Principal Deputy Director Douglas R. Lowy said at the annual meeting of the Association of American Cancer Institutes.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- Wafik El-Deiry carted a bunch of books around the Mediterranean
Here are his reviews - What are you reading in 2024?
- FDA’s Brian Booth: “We need to reconsider our approach to dose selection”
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Senate Appropriations Committee slates $1.77B increase for NIH, $270M for NCI in FY25